Background Image
Table of Contents Table of Contents
Previous Page  26 / 68 Next Page
Information
Show Menu
Previous Page 26 / 68 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 31, No 2, March/April 2020

78

AFRICA

by RHC were found to be independent predictors of functional

capacity in PAH patients.

PwD has been used in an extensive list of clinical conditions.

P-wave duration and PwD reveal prolongation of the intra- and

inter-atrial conduction time and inhomogeneous propagation

of sinus impulses, which are well-known electrophysiological

characteristics in patients with atrial arrhythmias and especially

paroxysmal atrial fibrillation.

5

PwD has been used in the

assessment of risk for atrial fibrillation in patients without

obvious heart disease, coronary artery disease, hypertension,

valvular heart diseases, heart failure, congenital heart diseases,

rheumatological diseases and various clinical situations.

5

PwD

has been demonstrated to be a sensitive and specific ECG

predictor of atrial fibrillation in various clinical settings.

5

In our

study, we found a strong correlation between PwD, mPAP and

functional status in PAH patients.

Factors reflecting RV function as assessed by RHC, including

Table 3. Multiple linear regression model to identify independent

predictors of 6MWD test for functional capacity of PAH patients

Model

Unstandardised coefficients

Standardised

coefficients

p-value

B

Std error

Beta

1 (Constant)

694.18

261.15

0.01

TAPSE

–5.33

9.81

–0.09

0.59

ProBNP

–0.007

0.02

–0.05

0.73

PwD

–1.09

0.44

–0.30

0.02

RV size

–13.72

25.29

–0.07

0.59

PVR

8.73

6.06

0.41

0.16

CI

2.61

87.58

0.007

0.97

sPAP echo

–0.68

0.84

–0.16

0.42

Age

0.51

0.91

0.07

0.57

MeanPAPcath

–4.15

1.48

–0.92

0.01

2 (Constant)

699.25

194.06

TAPSE

–5.28

9.43

–0.09

ProBNP

–0.007

0.02

–0.05

PwD

–1.09

0.40

–0.30

RV size

–13.54

24.01

–0.06

PVR

8.66

5.46

0.41

sPAP echo

–0.69

0.80

–0.16

Age

0.53

0.78

0.07

MeanPAPcath

–4.15

1.45

–0.92

3 (Constant)

692.31

189.47

TAPSE

–4.95

9.21

–0.09

0.59

PwD

–1.12

0.39

–0.31

<

0.01

RV size

–13.09

23.54

–0.06

0.58

PVR

8.12

5.15

0.38

0.12

sPAP echo

–0.79

0.73

–0.18

0.29

Age

0.64

0.7

0.09

0.37

MeanPAPcath

–4.06

1.4

–0.9

<

0.01

4 (Constant)

599

74.61

<

0.001

PwD

–1.11

0.38

–0.31

<

0.01

RV size

–13.6

23.18

–0.06

0.56

PVR

8.11

5.07

0.38

0.12

sPAP echo

–0.75

0.72

–0.17

0.30

Age

0.56

0.68

0.07

0.41

MeanPAPcath

–3.76

1.26

–0.83

<

0.01

MeanPAPcath, mean catheter pressure of pulmonary artery; 6MWD, six-

minute walk distance; sPAP echo, systolic pulmonary arterial pressure measured

with echocardiography; TAPSE, tricuspid annular-plane systolic excursion;

ProBNP, N-terminal brain natriuretic peptide; PVR, pulmonary vascular resis-

tance; CI, cardiac index; RV, right ventricular; PwD, P-wave dispersion.

Table 4. Multiple linear regression model to identify independent

predictors of 6MWD test for functional capacity of PAH patients

Model

Unstandardised coefficients

Standardised

coefficients

p-value

B

Std error

Beta

5 (Constant)

565.46

47.33

<

0.001

PwD

–1.2

0.34

–0.33

<

0.01

PVR

7.88

4.99

0.37

0.12

sPAP echo

–0.78

0.71

–0.18

0.27

Age

0.62

0.66

0.08

0.36

MeanPAPcath

–3.83

1.24

–0.85

<

0.01

6 (Constant)

596.5

33.55

<

0.001

PwD

–1.16

0.34

–0.32

<

0.01

PVR

7.79

4.98

0.37

0.129

sPAP echo

–0.64

0.69

–0.15

0.36

MeanPAPcath

–4.1

1.2

–0.91

<

0.01

7 (Constant)

574.83

24.06

<

0.001

PwD

–1.2

0.34

–0.33

<

0.01

PVR

7.20

4.93

0.03

0.15

MeanPAPcath

–4.54

1.108

–1.008

<

0.001

8 (Constant)

578.2

24.42

<

0.001

PwD

–1.37

0.32

–0.38

<

0.001

MeanPAPcath

–3.03

0.41

–0.67

<

0.001

MeanPAPcath, mean catheter pressure of pulmonary artery; 6MWD, six-

minute walk distance; sPAP echo, systolic pulmonary arterial pressure measured

with echocardiography; PVR, pulmonary vascular resistance; PwD, P-wave

dispersion.

Table 5. Correlation between echocardiographic and

ECG parameters in the patient population

TAPSE

RA size

RV size

sPAP echo

PwD

r

–0.31

0.05

0.51

0.36

p

0.07

0.74

< 0.01

0.04

TAPSE, tricuspid annular-plane systolic excursion; RA, right atrial; RV, right

ventricular; sPAP echo, systolic pulmonary arterial pressure measured with

echocardiography; PwD, P-wave dispersion.

Mean catheter pressure (mmHg)

Six-minute walk distance (m)

R

2

linear = 0.625

Fig. 3.

Correlations between the six-minute walk distance

and mean catheter pressure of the pulmonary artery

in scatterplots.

Table 6. Correlation between echocardiographic and

ECG parameters in the control group

TAPSE

RA size

RV size

PwD

r

–0.22

–0.09

–0.30

p

0.22

0.60

0.09

TAPSE, tricuspid annular-plane systolic excursion; RA, right atrial; RV, right

ventricular; PwD, P-wave dispersion.